National Institute of General Medical Sciences; Notice of Closed Meeting, 13759-13760 [2025-05153]
Download as PDF
Federal Register / Vol. 90, No. 57 / Wednesday, March 26, 2025 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of SBIR/STTR Applications
and Scientific Meetings & Conferences
Awards.
Date: April 14, 2025.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892.
Meeting Format: Virtual Meeting.
Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Bethesda, Maryland 20892, 301–402–
9448, sonia.ortiz-miranda@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: March 21, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–05154 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSK9W7S144PROD with NOTICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
VerDate Sep<11>2014
16:57 Mar 25, 2025
Jkt 265001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK RC2 SEP.
Date: April 11, 2025.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Xiaodu Guo, M.D., Ph.D.,
Scientific Review Officer, National Institutes
of Health, National Institute of Diabetes and
Digestive and Kidney Diseases, 6707
Democracy Boulevard, RM: 7345, Bethesda,
MD 20892–5452, (301) 594–4719, guox@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05068 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
13759
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Small Business
Innovation Research/Small Business
Technology Transfer Grant Applications.
Date: April 22–24, 2025.
Time: 8 a.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
NIMHD, DEM II, Suite 800, 6707 Democracy
Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Karen Nieves Lugo, MPH,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Office of Extramural
Research Administration, National Institute
on Minority Health and Health Disparities,
National Institutes of Health, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 480–4727, karen.nieveslugo@
nih.gov.
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05073 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: May 22, 2025.
Closed: 1:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Meeting Format: Virtual Meeting.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Erica L. Brown, Ph.D.,
Director Division of Extramural Activities,
National Institute of General Medical
E:\FR\FM\26MRN1.SGM
26MRN1
13760
Federal Register / Vol. 90, No. 57 / Wednesday, March 26, 2025 / Notices
Sciences, National Institutes of Health,
Natcher Building, Room 2AN24C, Bethesda,
MD 20892, 301–594–4499, erica.brown@
nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/about/council/Pages/
default, where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program No. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05036 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
Dated: March 21, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2025–05153 Filed 3–25–25; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSK9W7S144PROD with NOTICES
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group; Fellowships in
Diabetes Endocrinology and Metabolic
Diseases Fellowships in Diabetes
Endocrinology and Metabolic Diseases
(DDK–E).
Date: June 11–12, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tori Stone, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 827–0994, tori.stone@nih.gov.
VerDate Sep<11>2014
16:57 Mar 25, 2025
Jkt 265001
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Clinical
Topics in Neuroimmunology and
Neuroinflammation.
Date: April 17–18, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Gek Ming Sia, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 480–3341,
gekming.sia@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Oxidative
Stress, and Synaptic Plasticity.
Date: April 21–22, 2025.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Steven A. Ripp, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–594–3010, steven.ripp@nih.gov.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Autoimmunity and Inflammation.
Date: May 21, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Deanna C. Bublitz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–4005, deanna.bublitz@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 20, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–05076 Filed 3–25–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; HEAL Initiative:
NIH–DOD–VA Pain Management
Collaboratory Pragmatic and/or
Implementation Science Demonstration
Projects ((UG3/UH3) Clinical Trial Required).
Date: April 21–23, 2025.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Center for
Complementary and Integrative Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892.
E:\FR\FM\26MRN1.SGM
26MRN1
Agencies
[Federal Register Volume 90, Number 57 (Wednesday, March 26, 2025)]
[Notices]
[Pages 13759-13760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05153]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
General Medical Sciences Council.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory General Medical Sciences
Council.
Date: May 22, 2025.
Closed: 1:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Meeting Format: Virtual Meeting.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Erica L. Brown, Ph.D., Director Division of
Extramural Activities, National Institute of General Medical
[[Page 13760]]
Sciences, National Institutes of Health, Natcher Building, Room
2AN24C, Bethesda, MD 20892, 301-594-4499, [email protected].
Information is also available on the Institute's/Center's home
page: https://www.nigms.nih.gov/about/council/Pages/default, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program No. 93.859,
Biomedical Research and Research Training, National Institutes of
Health, HHS)
Dated: March 21, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-05153 Filed 3-25-25; 8:45 am]
BILLING CODE 4140-01-P